Skip to content

Mentalisation-based treatment for socially isolated older adults with personality disorder

A mixed methods pilot study exploring the feasibility, acceptability and potential benefits of mentalisation-based treatment for older adults with complex emotional needs

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42639791
Enrollment
14
Registered
2025-12-16
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of suicidality, self-harm, personality functioning and loneliness in older adults with personality disorder Mental and Behavioural Disorders

Interventions

This study uses a multiple single case series design, a form of Single Case Design (SCD). It will employ quantitative methods to track changes in personality functioning over time using the LPFS 2.0 s

Sponsors

Greater Manchester Mental Health NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Resident of Manchester, England 2. Aged 65 or over 3. Confirmed Personality Disorder diagnosis via the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD) or significant associated traits (Personality Disorder trait specified according to DSM-5). If individuals don't fully meet the criteria, their sub-threshold presentation will be explicitly noted (one criterion less than the cut-off point for the personality disorder) 4. Ability to provide informed consent 5. Under the care of a local community mental health team

Exclusion criteria

Exclusion criteria: 1. Primary issues related to psychosis, dementia, or mild cognitive impairment 2. Primary concerns associated with antisocial personality disorder or significant violent/aggressive traits 3. Ability to attend the outpatient clinic (free transport provided) 4. A diagnosis of autism won't be an exclusion criterion if all other inclusion criteria are met. The study's service site has seen referrals for individuals with autism over the past 18 months, and they've shown improvement in their outcome measures.

Design outcomes

Primary

MeasureTime frame
1. Changes in personality functioning will be measured using the Level of Personality Functioning Scale Brief Form (LPFS-BF 2.0) administered weekly, following each individual therapy session 2. Loneliness will be measured using the Social Isolation Short Form 4a, administered weekly, following each individual therapy session 3. Service use will be investigated to determine if there is any potential cost saving for the NHS. Participants will be asked to consent to the research team to take a record of: 3.1. Unplanned contact with the service 3.2. A and E attendances 3.3. Crisis line contacts 3.4. Days in psychiatric hospital 3.5. Days spent in the general hospital 4. Self-harm and suicidal behaviour will be measured by collecting data on incidents of self-harm recorded in the clinical record, and incidents where the participant has engaged in self-injury or self-neglect, where they intended to cause life-threatening injury

Secondary

MeasureTime frame
The following secondary outcome measures will be assessed at the start of baseline, start of treatment, 6, 12, 18 months into the treatment and at the end of follow-up: 1. Quality of Life will be measured using the Recovering Quality of Life (ReQol-10) scale 2. Patient Satisfaction will be measured using the Dialog Satisfaction Scale 3. Suicidality will be measured using the Columbia Suicidality Response Severity Scale (CSRSS)

Countries

England, United Kingdom

Contacts

Public ContactLuke Jordan
luke.jordan@gmmh.nhs.uk+44 (0)1612710322

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026